Pliant Therapeutics Stock (PLRX Stock) is the stock belonging to Pliant Therapeutics Inc., a medical research company. PLRX Stock price has been around $8 for most of the last year, but the PLRX Stock price has risen to more than twice its former value, and PLRX stock forecast has caught the eye of analysts. Pliant Therapeutics IPO has been announced on June 2, 2020, with 9,000,000 shares of its common PLRX stock with the price of $16 per share. Pliant Therapeutics stock began being traded in the Nasdaq Global Select Market on June 3, 2020, with the ticker name PLRX.
Pliant Therapeutics stock price has seen an increase in value in the first year and the two quarters after the Pliant IPO was announced, but has seen a major decrease in value in the following year when the Pliant Therapeutics stock price fell as low as $3.96. However, in the last month, in July 2022, the PLRX Stock price has risen to high point of $23.00, signaling a break from the decrease of value the PLRX Stock price was going through. The forecasts indicate that in the next year this break may accomplish an even larger increase in value, however, the situation may be different for longer term investments.
What Does Pliant Therapeutics Inc. do?
Pliant Therapeutics Inc. is a biopharmaceutical company, focusing on helping fibrosis treatments with the discovery and development of new theories and better understanding the drivers of fibrotic diseases on the molecular level. With the income provided from PLRX stocks, Pliant Therapeutics Inc. develops novel treatments and does important work to change the understanding of fibrotic diseases and to provide patients with safe and effective treatments. They are a major company in the life science field in the current market. They also have additional research projects on topics such as an oncology program based on their approach to integrity in their fibrosis medications, and they also have a program aiming to treat muscle dystrophies. Pliant Therapeutics Inc is a company based in San Francisco, California.
Is Pliant Therapeutics Stock a Good Buy?
Pliant Therapeutics stock price has the tendency to go through periodic rises and declines. However, Pliant Therapeutics news and PLRX stock forecasts show that it has been subject to numerous new highs and very high increases in value in the last two months. PLRX stock forecasts rate the PLRX stock as a strong buy at the moment. The Pliant Therapeutics stock price is also higher than the PLRX stock price when the Pliant Therapeutics IPO was first announced. PLRX stocks are expected to reach a target value of $38.00, with a maximum value going as high as $51.00. PLRX stock forecasts from Wall Street analysts give the Pliant Therapeutics stock 3 strong buys and 4 buys opinions. You can buy PLRX stocks from a brokerage firm of your choosing, but it is important to do the necessary market research before investing in Pliant Therapeutics stocks.
Will Pliant Therapeutics Stock Price Go Up?
The PLRX stock is a valuable stock that can see rapid increases in value. PLRX stocks are an important source of funding for the successful company Pliant Therapeutics Inc in their research against fibrotic diseases. According to the recent increases in value PLRX stock forecasts suggest a larger increase in value to come and Pliant Therapeutics news showing new yearly highs, experts definitely seem to be suggesting investors to buy PLRX stocks. Pliant Therapeutics stock prices are currently higher than the value announced at Pliant IPO, and PLRX stock forecasts suggest that the PLRX stock prices will increase in the next year.
Should I Buy or Sell Pliant Therapeutics Stock Right Now?
Pliant Therapeutics stock prices have seen a lot of fluctuation since the Pliant IPO was first announced. However, in the last 2 months, PLRX stocks rose over twice their average value for the last year, and PLRX stock forecasts mostly suggest even more of an increase in value to happen in the upcoming period. According to the data provided by experts and the latest Pliant Therapeutics news, long term investments to this stock may pay out in the investors favor. Pliant Therapeutics Inc. is a valuable company capable of generating a high amount of revenue, but caution is advised because there may be periods of time the PLRX stocks lose value.
Pliant Therapeutics also announced a new public offering of their shares, aiming to increase their revenue, which means the Pliant Therapeutics stock prices will be affordable until 15 July 2022. The price set for this public offering is $18.50, $2.50 higher than the Pliant Therapeutics IPO. This upsizing may mean that the company is entering a stage which will generate larger sums of revenue, and PLRX stock forecasts predict a rise in value as well.
What is Pliant Therapeutics’ Stock Price Forecast for 2022?
According to the market analysts, PLRX stock forecasts predict the average yearly PLRX stock price will be $38.76, suggesting an increase of %89.91, with the lowest target value being $27.27 and the highest being %53.55. This suggests a minimum of %33 increase in PLRX stock prices in the next year. PLRX stocks are in a good position for buying right now, according to the market research. Of course, these forecasts are only predictions and PLRX stock prices can also be susceptible to periods of losing value.
PLRX Stock Forecast 2022, 2023, 2024, 2025, 2030
While the PLRX stock value is predicted to rise for the next year, the PLRX stock forecasts for the next 3 years show a different story. The predicted rise in the PLRX stock prices are only made for the yearly period, and 3 year analysis’ show that in the longer period, the growth rate of revenues and returns are below the average growth of the American market, suggesting that this may be a dangerous long term investment. While none of these can predict the future accurately, this analysis at least indicates that extensive market research should be made before making a long term investment in PLRX stocks.